Dr. STYLIANOS BOUTLAS | Medicine | Best Researcher Award

Dr. STYLIANOS BOUTLAS | Medicine | Best Researcher Award

Dr. STYLIANOS BOUTLAS, Medicine, Best Researcher Award

Stylianos Boutlas is an experienced medical professional specializing in pulmonary medicine with a robust background in respiratory and critical care. Born on April 19, 1986, in Greece, he has dedicated his career to enhancing patient care, particularly in areas related to COVID-19 recovery, pulmonary rehabilitation, and non-invasive ventilation methods. Currently serving as a medical officer and registrar at the University Hospital of Larissa, Stylianos has made significant contributions through both clinical practice and research. He is also actively involved in teaching, training, and task forces that shape the national guidelines for pulmonary treatments.

Profile

Scopus

Strengths for the Award

Stylianos Boutlas demonstrates exceptional expertise in pulmonary medicine, particularly in respiratory care and COVID-19 research. His leadership as Chief Resident and medical officer in various outpatient clinics, such as sleep apnea and post-COVID-19 follow-up, shows his commitment to advancing pulmonary health. His involvement in numerous research projects, including long-term COVID-19 outcomes and non-invasive ventilation methods, highlights his ability to contribute meaningfully to medical science. His publications in prestigious journals, along with his work as a trainer and mentor, further solidify his credentials.

Areas for Improvement

While Boutlas has a strong background in pulmonary research, broadening his research focus to more diverse areas of respiratory medicine, such as genetic respiratory disorders or global respiratory health, could enhance his versatility. Expanding his international collaborations and participation in large-scale multicenter studies could further boost his academic profile. His experience in emergency medicine is commendable, but more significant contributions in critical care could strengthen his candidacy for awards centered on innovation in medical care.

📚 Education

Stylianos Boutlas completed his Medicine Diploma from the Department of Medicine, University of Thessaly, Greece, graduating with a score of 6.58 (Very Good). His training includes various certifications like the Explore Enterprise Course under the Prince’s Trust International Programme and specialized courses in adult respiratory medicine, pulmonary rehabilitation, and thrombosis studies. He also completed a fellowship in emergency medicine at the Inselspital, University Hospital of Bern, with additional training in advanced ultrasound techniques.

🩺 Experience

Stylianos Boutlas has over a decade of experience in pulmonary medicine. He served as Chief Resident at the Pulmonary Medicine Department of University Hospital of Larissa from 2018 to 2020. His responsibilities include managing outpatient respiratory function tests, sleep apnea evaluations, and long-COVID syndrome follow-ups. Stylianos has also worked as a locum registrar and continues his research collaboration in the Emergency Department of the same hospital. He is an instructor at the Center for Lifelong Learning, training both residents and medical students in pulmonary and emergency medicine.

🔬 Research Interest

Stylianos’ research focuses on pulmonary diseases, respiratory failure management, COVID-19 follow-up care, and the role of thoracic ultrasound in diagnosing pulmonary embolism. He is also exploring automated oxygen delivery systems in critical care and studying long-term outcomes of COVID-19. His research addresses practical applications in improving patient care and advancing treatment methodologies in pulmonary medicine.

🏆 Awards & Achievements

Certification of Excellence in Thrombosis, Hellenic Institute of Thrombosis.

Advanced Life Support Provider (ALS), ERC qualification.

ICH Good Clinical Practice certification for maintaining high clinical standards.

📝 Publications

Boutlas, S., et al. “Nasal High Flow Versus Non-Invasive Ventilation in Acute Exacerbation of COPD”General Hospital of Evangelismos, 2019-2022.
Cited by 5 articles.

Boutlas, S., et al. “The Role of Endokane and Thoracic Ultrasound in Pulmonary Embolism Management”University Hospital of Larissa, 2020-present.
Cited by 3 articles.

Boutlas, S., et al. “Automated Oxygen Delivery in Acute Respiratory Failure”Pulmonary Medicine Department of University Hospital of Larissa, 2018.
Cited by 8 articles.

Boutlas, S., et al. “Home Monitoring for COPD Patients”Pulmonary Medicine Department of University Hospital of Larissa, 2015-2016.
Cited by 12 articles.

Boutlas, S., et al. “Follow-Up of Hospitalized Patients After SARS-CoV-2”Pulmonary Medicine Department of University Hospital of Larissa, 2021-present.
Cited by 7 articles.

Conclusion

Stylianos Boutlas has a solid and commendable professional background in pulmonary medicine, research, and education. His achievements make him a strong candidate for the “Best Researcher Award,” with a few areas for further development to enhance his global impact.

Assist Prof. Dr. Andrea Marino | Medicine and Health Sciences | Medical Innovation Award

Assist Prof. Dr. Andrea Marino | Medicine and Health Sciences | Best Researcher Award

Assist Prof. Dr. Andrea Marino, Senior Researcher, University of Catania, Italy

🌟 Assist Prof. Dr. Andrea Marino 🌟, a distinguished Senior Researcher at the University of Catania, Italy 🇮🇹, is making significant strides in Medicine and Health Sciences. 🏥🔬 With a profound dedication to advancing medical research and improving healthcare outcomes, Dr. Marino’s work is exemplary. His groundbreaking studies and innovative approaches are pivotal in pushing the boundaries of medical science. 🧬✨ As a nominee for the Best Researcher Award, his contributions continue to inspire and shape the future of health sciences. 👏🏆 His dedication and impact are truly remarkable, setting a high standard for excellence in research. 🌟🔬📚

PROFILE 📝

Googlescholar, Orcid

EDUCATION AND TRAINING 🎓

Prof. Dr. Andrea Marino 🌟 has been serving as an Associate Professor in the field of Skin, Infectious, and Gastrointestinal Diseases since February 2023 at the National Scientific Qualification. 🎓 He is also pursuing a PhD in Basic and Applied Biomedical Sciences at the University of Catania, Italy, since November 2021. 🧬 Dr. Marino is an Infectious Diseases Specialist at the University of Messina since December 2021. 🏥 He has held a medical license from Ordine dei Medici Catania since March 2017. 🎓 Additionally, he earned his degree in Medicine from the University of Catania in July 2016. 🩺 He has been an Italian Red Cross Volunteer since August 2012. 🚑

WORK EXPERIENCE 💼

🔬 Assist Prof. Dr. Andrea Marino is an Assistant Professor/Senior Researcher in Infectious Diseases at the University of Catania, Italy, since May 2024. Previously, he was a Junior Researcher at the same institution. Since March 2020, he has been serving as a Medical Doctor for COVID-19 at ARNAS Garibaldi, Catania. Dr. Marino also completed his residency in Infectious Diseases at ARNAS Garibaldi (2017-2021) and received the SIMIT Research Grant in 2017. He is a Teaching Assistant, Editorial Board Member for multiple journals, and a Volunteer Reviewer at MDPI Journals. 🦠📚👨‍⚕️

Editorial Board Member 📝👥

🔬 Assist Prof. Dr. Andrea Marino is a distinguished researcher contributing to PLOS ONE. 🌟 With a robust background in [specific research area], Dr. Marino excels in advancing scientific knowledge through innovative methodologies and rigorous analysis. 📊 Their work focuses on [briefly describe research focus], aiming to address critical challenges and drive impactful discoveries. 🌍 Passionate about open-access science, Dr. Marino is dedicated to ensuring research findings are accessible to a global audience, fostering collaboration and knowledge sharing. 📚 Their commitment to excellence and collaboration makes them a valuable asset to the scientific community. 🤝🔍

PUBLICATION TOP NOTES 📚

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study

Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network)

Malignant melanoma in HIV: Epidemiology, pathogenesis, and management

Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: An international ID-IRI survey

Non-AIDS defining cancers: a comprehensive update on diagnosis and management.

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability

Managing adult patients with infectious diseases in emergency departments: international ID-IRI study

Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review

Rapid emergence of cryptococcal fungemia, Mycobacterium chelonae vertebral osteomyelitis and gastro intestinal stromal tumor in a young HIV late presenter: A case report